Novartis may have the most new drug approvals, but Roche, Lilly and AbbVie's launches win on value: report

15th July 2021 Uncategorised 0

Novartis may have the most new drug approvals, but Roche, Lilly and AbbVie’s launches win on value: report
fkansteiner
Thu, 07/15/2021 – 11:22

More: Novartis may have the most new drug approvals, but Roche, Lilly and AbbVie's launches win on value: report
Source: fierce